journal article·2016-05

A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery

Varadharajan Thiyagarajan, Shi-Xiang Lin, Chia-Hung Lee, Ching-Feng Weng

Publisher page

Abstract

16-Hydroxy-cleroda-3,13-dien-16,15-olide (HCD) which is extracted from a medicinal plant, Polyalthia longifolia, was shown to exhibit anticancer activity through apoptosis and FAK inhibition in our previous study. To improve its solubility and efficacy, a novel HCD delivery system using copper-substituted mesoporous silica nanoparticles (MSNs) was designed as a delivery vehicle, and the outer surfaces of MSNs were further coated with enteric polymers to prevent the drug from leaching in the stomach acid. All the data regarding synthesis and physical characterization, including Zeta potential, FT-IR spectra, N2 adsorption-desorption isotherms (BET), drug loading, powder X-ray diffraction, Thermo gravimetric analysis (TGA), Transmission electron microscopy (TEM), and Scanning electron microscopy (SEM) were well characterized. The non-coated MSN-HCD exposed to acidic pH (1.2) showed a rapid degradation of the drug, whereas the enteric-coated samples presented a sustained release profile in the gastrointestinal pHs. Cell cytotoxicity was further confirmed by the MTT-C6 Glioma cell line, in vitro. When compared with the control and pure HCD, the MSN-HCD revealed a potential anti-proliferation effect via the synergistic effect of the drug and the MSN vehicle. Additionally, this MSN-HCD had the effect of increasing the reactive oxygen species (ROS) levels and altered the Mitochondria membrane potential (MMP) in C6 cell line. The in vivo anti-tumor efficacy of enteric-coated MSN-HCD was evaluated by C6 Glioma bearing xenograft nude mice, and enteric-coated MSN-HCD clearly exhibited the greatest anti-glioma activity, as compared to the pure HCD and the untreated control. In terms of the effective treatment of brain glioma, this study provides conclusive evidence of the successful development of the anti-cancer agent HCD conjugated with enteric-coated MSN as a delivery control mechanism with enhanced dissolution characteristics.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. World Health Organization classification of tumors10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F ↗
2. Malignant gliomas in adults10.1056/NEJMra0708126 ↗
4. Recent developments in the use of chemotherapy in brain tumours10.1016/j.ejca.2005.06.031 ↗
5. Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems10.1080/10611860410001712696 ↗
6. Integrated approaches towards drug development from Ayurveda and other Indian system of medicines10.1016/j.jep.2005.09.024 ↗
7. Antimicrobial activity of clerodane diterpenoids from Polyalthia longifolia seeds10.1016/j.fitote.2005.02.005 ↗
8. Cytotoxic constituents of Polyalthia longifolia var. pendula10.1021/np000176e ↗
9. Anti-inflammatory and cytotoxic diterpenes from formosan Polyalthia longifolia var. pendula10.1055/s-2006-951691 ↗
10. 16-Hydroxycleroda-3,13-dien-15,16-olide regulates the expression of histone-modifying enzymes PRC2 complex and induces apoptosis in CML K562 cells10.1016/j.lfs.2011.09.011 ↗
11. Drug-like properties and the causes of poor solubility and poor permeability10.1016/S1056-8719(00)00107-6 ↗
12. Drug nanoparticles: formulating poorly water-soluble compounds10.1177/0192623307310946 ↗
13. Characterization of nanoparticles for therapeutics10.2217/17435889.2.6.789 ↗
14. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells10.1016/j.jcis.2011.11.024 ↗
15. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism10.1038/359710a0 ↗
16. A new property of MCM-41: drug delivery system10.1021/cm0011559 ↗
17. Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties10.1016/j.ijpharm.2010.07.040 ↗
18. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica10.1016/j.ejps.2010.09.002 ↗
19. Encapsulating magnetic and fluorescent mesoporous silica into thermosensitive chitosan microspheres for cell imaging and controlled drug release in vitro10.1016/j.colsurfb.2013.08.015 ↗
20. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles10.1016/j.ijpharm.2009.12.023 ↗
21. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs10.1002/smll.200700005 ↗
22. Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery10.1016/j.colsurfb.2014.02.014 ↗
23. Lethal drug combination: arsenic loaded multiple drug mesoporous silica for theranostic applications10.1016/j.colsurfb.2014.09.046 ↗
24. Novel metals and metal complexes as platforms for cancer therapy10.2174/138161210791209009 ↗
25. Thioamido coordination in a thioxo-1,2,4-triazole copper(II) complex enhances nonapoptotic programmed cell death associated with copper accumulation and oxidative stress in human cancer cells10.1021/jm061174f ↗
26. Synthesis structure and biological activity of copper(II) complexes of 4-(2-pyridylmethyl)-1,7-dimethyl-1,4,7-triazonane-2,6-dione and 4-(2-pyridylethyl)-1,7-dimethyl-1,4,7-triazonane-2,6-dione10.1016/j.ejmech.2008.07.029 ↗
27. Antroquinonol targets FAK-signaling pathway suppressed cell migration, invasion, and tumor growth of C6 glioma10.1371/journal.pone.0141285 ↗
28. Protective effect of erythropoietin on beta-amyloid-induced PC12 cell death through antioxidant mechanisms10.1016/j.neulet.2008.07.007 ↗
29. Multi-laminated metal hydroxide nanocontainers for oral-specific delivery for bioavailability improvement and treatment of inflammatory paw edema in mice10.1016/j.jcis.2015.07.044 ↗
30. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels10.1016/j.colsurfb.2009.03.010 ↗
31. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery10.1016/j.biomaterials.2009.07.020 ↗
32. Copper transport and Alzheimer’s disease10.1007/s00249-007-0235-2 ↗
33. Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts10.1016/j.leukres.2007.06.023 ↗
34. The relationship between serum copper and ceruloplasmin in routine clinical practice10.1111/j.1742-1241.2007.01643.x ↗
35. Genetic and molecular basis for copper toxicity10.1093/ajcn/63.5.836 ↗
36. Associations of dietary and serum copper with inflammation, oxidative stress, and metabolic variables in adults10.1093/jn/138.2.305 ↗
37. Mitochondria at the crossroad of apoptotic cell death10.1023/A:1005471701441 ↗
38. Mitochondrial proteolysis: its emerging roles in stress responses10.1016/j.bbagen.2014.10.012 ↗
39. A novel inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide, blocks the autophosphorylation site of focal adhesion kinase (Y397) by molecular docking10.1016/j.bbagen.2013.04.027 ↗
40. Elesclomol induces cancer cell apoptosis through oxidative stress10.1158/1535-7163.MCT-08-0298 ↗
41. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells10.1016/j.freeradbiomed.2012.03.017 ↗
42. Anti-cancer activity of bromelain nanoparticles by oral administration10.1166/jbn.2014.1997 ↗
43. Clinical pharmacology of anticancer agents in relation to formulations and administration routes10.1053/ctrv.1998.0107 ↗
44. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies10.1002/jps.22113 ↗
45. Nanocarriers for oral drug delivery10.3109/1061186X.2013.789033 ↗
46. Nanoparticles of 2-deoxy-d-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment10.1016/j.biomaterials.2013.09.094 ↗
47. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles10.1016/j.biomaterials.2012.07.046 ↗